These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 9610729

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cellular models of drug- and radiation-resistant small cell lung cancer.
    Davey RA, Locke VL, Henness S, Harvie RM, Davey MW.
    Anticancer Res; 2004; 24(2A):465-71. PubMed ID: 15152945
    [Abstract] [Full Text] [Related]

  • 5. Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression.
    Henness S, Davey MW, Harvie RM, Davey RA.
    Int J Radiat Oncol Biol Phys; 2002 Nov 01; 54(3):895-902. PubMed ID: 12377343
    [Abstract] [Full Text] [Related]

  • 6. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C, Maruyama M, Fujishita T, Dohkan J, Oda H, Shinoda K, Yamada T, Miyabayashi K, Hayashi R, Kawagishi Y, Fujita T, Matsui S, Sugiyama E, Muraguchi A, Kobayashi M.
    Int J Cancer; 2005 Oct 20; 117(1):21-31. PubMed ID: 15880572
    [Abstract] [Full Text] [Related]

  • 7. In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
    Jensen PB, Holm B, Sorensen M, Christensen IJ, Sehested M.
    Br J Cancer; 1997 Oct 20; 75(6):869-77. PubMed ID: 9062409
    [Abstract] [Full Text] [Related]

  • 8. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6.
    Ishii M, Iwahana M, Mitsui I, Minami M, Imagawa S, Tohgo A, Ejima A.
    Anticancer Drugs; 2000 Jun 20; 11(5):353-62. PubMed ID: 10912951
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle.
    Locke V, Davey R, Davey M.
    Cytometry; 2001 Mar 01; 43(3):170-4. PubMed ID: 11170102
    [Abstract] [Full Text] [Related]

  • 10. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
    Hill BT, Whelan RD, Shellard SA, McClean S, Hosking LK.
    Invest New Drugs; 1994 Mar 01; 12(3):169-82. PubMed ID: 7896535
    [Abstract] [Full Text] [Related]

  • 11. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein.
    Siegsmund MJ, Kreukler C, Steidler A, Nebe T, Köhrmann KU, Alken P.
    Urol Res; 1997 Mar 01; 25(1):35-41. PubMed ID: 9079744
    [Abstract] [Full Text] [Related]

  • 12. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
    Jensen PB, Christensen IJ, Sehested M, Hansen HH, Vindeløv L.
    Br J Cancer; 1993 Feb 01; 67(2):311-20. PubMed ID: 8094293
    [Abstract] [Full Text] [Related]

  • 13. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
    Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Tong Y, Belani CP, Gutheil JC.
    Br J Cancer; 1995 Sep 01; 72(3):535-42. PubMed ID: 7669558
    [Abstract] [Full Text] [Related]

  • 14. Extended multidrug resistance in haemopoietic cells.
    Marks DC, Su GM, Davey RA, Davey MW.
    Br J Haematol; 1996 Dec 01; 95(4):587-95. PubMed ID: 8982031
    [Abstract] [Full Text] [Related]

  • 15. In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines.
    Ikubo S, Takigawa N, Ueoka H, Kiura K, Tabata M, Shibayama T, Chikamori M, Aoe K, Matsushita A, Harada M.
    Anticancer Res; 1999 Dec 01; 19(5B):3985-8. PubMed ID: 10628341
    [Abstract] [Full Text] [Related]

  • 16. DNA repair rate and etoposide (VP16) resistance of tumor cell subpopulations derived from a single human small cell lung cancer.
    Hansen LT, Lundin C, Helleday T, Poulsen HS, Sørensen CS, Petersen LN, Spang-Thomsen M.
    Lung Cancer; 2003 May 01; 40(2):157-64. PubMed ID: 12711116
    [Abstract] [Full Text] [Related]

  • 17. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
    Nokihara H, Yano S, Nishioka Y, Hanibuchi M, Higasida T, Tsuruo T, Sone S.
    Jpn J Cancer Res; 2001 Jul 01; 92(7):785-92. PubMed ID: 11473730
    [Abstract] [Full Text] [Related]

  • 18. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.
    Rhodes T, Twentyman PR.
    Br J Cancer; 1992 May 01; 65(5):684-90. PubMed ID: 1316774
    [Abstract] [Full Text] [Related]

  • 19. Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
    Jensen PB, Roed H, Sehested M, Demant EJ, Vindeløv L, Christensen IJ, Hansen HH.
    Cancer Chemother Pharmacol; 1992 May 01; 31(1):46-52. PubMed ID: 1360876
    [Abstract] [Full Text] [Related]

  • 20. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK, Davey MW, Davey RA.
    Cancer Chemother Pharmacol; 2006 Aug 01; 58(2):256-65. PubMed ID: 16283310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.